Aptevo Therapeutics (APVO) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-18.04
-12.19
-6.35
-0.5

Details

Expected EPS
-1.93
Actual EPS
-1.67
Surprise EPS
0.26
Surprise Percent
+13.47%

Description

Aptevo Therapeutics (APVO) has reported earnings of -1.67 per share for Q3 2024.

0 Comments

Share your thoughts